HaplScience
PrivateLast Round
Series B
Jan 19, 2021
Total Funding Raised
$29.19M
Company Overview
HaplScience operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in January 2021.
HaplScience is a biotechnology company developing first-in-class therapies for chronic diseases and aging-related conditions based on the HAPLN1 protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HaplScience Comparables
Compare HaplScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediSpan Co., Ltd. | 82% | |
| Juvena Therapeutics | 81% | |
| Oisín Biotechnologies | 80% |
For institutional investors. Book with your work email.
HaplScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 19, 2021 | ||||
| Series A | Jul 12, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HaplScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series B, Series A |
| Ministry of Science and ICT of South Korea | Grant |
| Company K Partners | Series B, Series A |
| JB Investment | Series B |
| Lifecore Partners | Series B |
| STIC Ventures | Series B |
| National Research Foundation of Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 1160% MoM, reaching 1.7K.
- Nov 9, 2025
Monthly visitors grew 336% MoM, from 434 to 1.9K.
For institutional investors. Book with your work email.
HaplScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HaplScience's valuation, stock price, and market status.
Is HaplScience a public or private company?
HaplScience is a private company.
What is the current stock price of HaplScience?
HaplScience is a private company, so its shares have no public market price. Caplight tracks HaplScience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HaplScience worth (valuation)?
Valuation information for HaplScience is not publicly available.
Can I buy HaplScience stock?
HaplScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HaplScience's last funding round?
HaplScience's most recent funding round was Series B on January 19, 2021.
Who are the main investors in HaplScience?
Key investors in HaplScience include DSC Investment, Ministry of Science and ICT of South Korea, Company K Partners, JB Investment, Lifecore Partners.
Will HaplScience IPO soon?
No public IPO plans have been announced for HaplScience.
How can I track HaplScience secondary market activity?
Caplight tracks bids, offers, and trades in HaplScience's shares on secondary markets.